BATokines in metabolic liver disease: good cops or bad cops?
被引:0
|
作者:
Pereira, Renata O.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Iowa, Roy J & Lucille A Carver Coll Med, Eagles Diabet Res Ctr, Div Endocrinol Metab & Diabet & Fraternal Order, Iowa City, IA USAUniv Iowa, Roy J & Lucille A Carver Coll Med, Eagles Diabet Res Ctr, Div Endocrinol Metab & Diabet & Fraternal Order, Iowa City, IA USA
Pereira, Renata O.
[1
]
Abel, E. Dale
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USAUniv Iowa, Roy J & Lucille A Carver Coll Med, Eagles Diabet Res Ctr, Div Endocrinol Metab & Diabet & Fraternal Order, Iowa City, IA USA
Abel, E. Dale
[2
]
机构:
[1] Univ Iowa, Roy J & Lucille A Carver Coll Med, Eagles Diabet Res Ctr, Div Endocrinol Metab & Diabet & Fraternal Order, Iowa City, IA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
The systemic regulation of metabolic dysfunction-associated liver disease remains poorly understood. In this issue, Hsiao et al (2024) identify PCPE-1 as a brown-adipose tissue-derived mediator of hepatic fibrosis, integrating context-dependent ER stress-signaling. Recent work identifies PCPE-1 as a brown-adipose tissue-derived systemic mediator of liver fibrosis in metabolic dysfunction-associated steatohepatitis.